Cory Kasimov


J.P. Morgan Reiterates Overweight on SAGE Therapeutics Inc (SAGE) Following Positive Top-Line Phase 2 Data

In a research report released on Monday, J.P.

J.P. Morgan Cuts Price Target For Puma Biotechnology Inc (PBYI) Following NDA Delay; Remains Positive

Shareholders of Puma Biotechnology Inc (NYSE:PBYI) are having a rough day as the company’s stock is down 23%, following the news that the company will …

J.P. Morgan Heads to Sidelines on Alkermes Plc (ALKS); Slashes Price Target

In a research report published Tuesday afternoon, J.P.

J.P. Morgan Weighs In On Two Healthcare Stocks: Celgene Corporation (CELG), Juno Therapeutics Inc (JUNO)

While JP Morgan Healthcare Conference, which has become an agenda-setting meeting for pharma and biotech, is taking place in San Francisco, J.P.

J.P. Morgan Reiterates Overweight on Celgene Corporation (CELG) Following Meeting With COO

In a research report issued today, J.P.

J.P. Morgan Weighs In on ZIOPHARM Oncology Inc Following 3Q:15 Update

In a research note released Thursday, J.P.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts